Birdwatch Note Rating
2023-03-16 01:05:03 UTC - HELPFUL
Rated by Participant: 822FDB5FDE227B82AD19368107A8C70A66B372818F4554FAA67978CD7D954DB2
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details